Ivan Koza
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 18
- Neutropenia and Cancer Infections 6
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 4
- Co-authors
- Jozef Mardiak (8 shared papers)Michal Mego (5 shared papers)Zuzana Syčová-Milá (4 shared papers)Mária Rečková (3 shared papers)Jana Obertová (3 shared papers)Libor Ebringer (2 shared papers)Ľuboš Drgoňa (2 shared papers)Jan Trupl (4 shared papers)
In The Last Decade
Ivan Koza
29 papers receiving 322 citations
Peers
Comparison fields: 5 of 64
- Oncology 163
- Cancer Research 33
- Hematology 22
- Reproductive Medicine 14
- Genetics 16
Countries citing papers authored by Ivan Koza
This map shows the geographic impact of Ivan Koza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Koza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Koza more than expected).
Fields of papers citing papers by Ivan Koza
This network shows the impact of papers produced by Ivan Koza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Koza. The network helps show where Ivan Koza may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Koza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 95 | |
| 2 | Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. | 2005 | 42 |
| 3 | 2005 | 33 | |
| 4 | Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. | 2005 | 28 |
| 5 | Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group. | 2000 | 15 |
| 6 | 1990 | 14 | |
| 7 | Histocompatible leukocyte transfusion during granulocytopenia. | 1971 | 13 |
| 8 | Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. | 2007 | 11 |
| 9 | Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study. | 2005 | 9 |
| 10 | Sequential development of chronic lymphocytic leukemia in a patient with polycythemia vera. | 1988 | 8 |
| 11 | 2011 | 8 | |
| 12 | Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). | 1990 | 7 |
| 13 | Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. | 1972 | 6 |
| 14 | 2009 | 6 | |
| 15 | 2008 | 6 | |
| 16 | Single versus combination chemotherapy of L1210 leukemia. | 1980 | 5 |
| 17 | 2009 | 4 | |
| 18 | 1990 | 4 | |
| 19 | 1992 | 3 | |
| 20 | Blastic crisis of chronic myelogenous leukaemia. | 1969 | 3 |
About Ivan Koza
Ivan Koza is a scholar working on Oncology, Hematology, Neurology, Genetics and Epidemiology, having authored 33 papers that have together received 336 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (6 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Research Studies (4 papers), Testicular diseases and treatments (4 papers), Cancer therapeutics and mechanisms (4 papers), Fungal Infections and Studies (3 papers), Neuroblastoma Research and Treatments (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Oncology (163 citations), Cancer Research (33 citations), Hematology (22 citations), Reproductive Medicine (14 citations) and Genetics (16 citations). Ivan Koza has collaborated with scholars based in Slovakia, Czechia and India. Frequent co-authors include Jozef Mardiak, Michal Mego, Zuzana Syčová-Milá, Mária Rečková, Jana Obertová, Libor Ebringer, Ľuboš Drgoňa, Jan Trupl, Vladimír Zajac and Tadeusz Pieńkowski. Their work appears in journals such as Chemotherapy, Oncology, Supportive Care in Cancer, Annals of Oncology and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.